JPS5953833B2 - Culture method and medium - Google Patents

Culture method and medium

Info

Publication number
JPS5953833B2
JPS5953833B2 JP16347781A JP16347781A JPS5953833B2 JP S5953833 B2 JPS5953833 B2 JP S5953833B2 JP 16347781 A JP16347781 A JP 16347781A JP 16347781 A JP16347781 A JP 16347781A JP S5953833 B2 JPS5953833 B2 JP S5953833B2
Authority
JP
Japan
Prior art keywords
medium
cyclodextrin
bordetella
culturing
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP16347781A
Other languages
Japanese (ja)
Other versions
JPS5867182A (en
Inventor
洋二 鈴木
厚 今泉
久夫 山口
正晴 金崎
章二 小野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP16347781A priority Critical patent/JPS5953833B2/en
Priority to US06/427,039 priority patent/US4500639A/en
Priority to AU89192/82A priority patent/AU554066B2/en
Priority to CA000413002A priority patent/CA1198702A/en
Priority to DE8282305465T priority patent/DE3279841D1/en
Priority to ES516507A priority patent/ES8404407A1/en
Priority to AT82305465T priority patent/ATE44979T1/en
Priority to EP82305465A priority patent/EP0077646B1/en
Priority to SU823505901A priority patent/SU1384206A3/en
Priority to KR8204639A priority patent/KR870001650B1/en
Publication of JPS5867182A publication Critical patent/JPS5867182A/en
Publication of JPS5953833B2 publication Critical patent/JPS5953833B2/en
Priority to MYPI87000101A priority patent/MY100052A/en
Expired legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】 本発明は、病原性菌として知られているボルデテラ(B
ordetella)属に属する微生物の培養方法と、
その際に使用される培地に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention utilizes Bordetella (B.
A method for culturing microorganisms belonging to the genus Ordetella;
Regarding the culture medium used at that time.

ボルデテラ属に属する微生物としては、百日咳菌、パラ
百日咳菌、気管支敗血症菌等があり、特に百日咳菌は、
100日つづくといわれる特有の咳を伴う、気管、気管
支、および小気管支がおかされる急性の感染症である百
日咳の主たる病原菌と;して知られている。
Microorganisms belonging to the Bordetella genus include Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica.
It is known as the main pathogen of pertussis, an acute infection of the trachea, bronchi, and small bronchi that is accompanied by a characteristic cough that lasts for 100 days.

従って、臨床上は、かかる百日咳菌等の迅速・確実な検
出が望まれており、そのためには臨床分離菌の生育を促
進するような培地が必要である。
Therefore, from a clinical standpoint, rapid and reliable detection of Bordetella pertussis and the like is desired, and for this purpose a culture medium that promotes the growth of clinically isolated bacteria is required.

また、百日咳の予防のために百日咳ワクチンが用いられ
ているが、通常菌浮遊液の形で調整されるワクチンを効
率良く生産するためにも、百日咳菌の生育を促進するよ
うな培地が望ましい。
Additionally, a pertussis vaccine is used to prevent pertussis, and in order to efficiently produce a vaccine that is usually prepared in the form of a bacterial suspension, a medium that promotes the growth of pertussis bacteria is desirable.

かかる目的のためには、従来、ボルナ・ジャングー培地
(BG培地)やステイナー・ショルテ(SS培地)培地
が用いられているが、かかる培地を用いた場合でも、百
日咳菌等は培地上で変異をおこし易く安定した培養が難
しく、特に、菌の接種数が少ない場合(103コロニー
のオーダー以下)には、生育が非常に不安定であるとい
う問題点があった。
Conventionally, Borna-Jangoo medium (BG medium) and Steiner-Scholte (SS medium) medium have been used for this purpose, but even when such medium is used, Bordetella pertussis and the like can mutate on the medium. The problem is that it is difficult to cultivate stably because it is easily stimulated, and especially when the number of inoculated bacteria is small (on the order of 103 colonies or less), the growth is very unstable.

本発明者らは、従来技術の欠点を改良し、ボルデテラ属
に属する微生物を安定にかつ効率良く培養する方法につ
き鋭意研究の結果、本発明に到達した。
The present inventors have arrived at the present invention as a result of intensive research into a method for stably and efficiently culturing microorganisms belonging to the genus Bordetella by improving the shortcomings of the prior art.

□ 即ち、本発明は、ボルデテラ属に属する微生物を培
養するに際し、培地中にシクロデキストリン又はその誘
導体を加えることを特徴とする、ボルデテラ属に属する
微生物の培養方法と、その際に使用される培地である。
□ That is, the present invention provides a method for culturing a microorganism belonging to the genus Bordetella, which is characterized by adding cyclodextrin or a derivative thereof to the medium when culturing the microorganism belonging to the genus Bordetella, and a medium used therein. It is.

゛ 本発明におけるボルデテラ属に属する微生物とは、
百日咳菌、パラ百日咳菌、気管支敗血症菌等をいう。
゛ The microorganisms belonging to the genus Bordetella in the present invention are
This refers to Bordetella pertussis, Bordetella pertussis, Bordetella bronchiseptica, etc.

ボルデテラ属に属する微生物の菌学的性質及び培養条件
等に関しては、Bergy’ s Manual
ofDeterminative Bacteriol
ogy、第8版、1974年、The William
s & Willkins Co0発行やJ、 E
xp、 Med、 129巻、第523−550頁、1
969年あるいは細菌学実習提要、第3版、第80頁以
下、昭和47年、丸首発行等があり、すでに公知である
Regarding the mycological properties and culture conditions of microorganisms belonging to the genus Bordetella, see Bergy's Manual
of Determinative Bacteriol
ogy, 8th edition, 1974, The William
Published by S & Willkins Co0, J, E
xp, Med, Vol. 129, pp. 523-550, 1
It is already publicly known, as it was published in 1969 or Bacteriology Practice Handbook, 3rd edition, pages 80 and below, in 1972, in a round neck.

シクロデキストリンは、でん粉あるいはでん粉の加水分
解物にBacillus maceransなどのam
ylaseを作用させて得られる、D−グリコピラノー
ス基が6〜10個α−1,4グルコシド結合によって環
状に結合した王冠状の分子である。
Cyclodextrin is a starch or starch hydrolyzate that is produced by bacteria such as Bacillus macerans.
It is a crown-shaped molecule obtained by the action of ylase, in which 6 to 10 D-glycopyranose groups are linked in a ring through α-1,4 glucosidic bonds.

そのうち主なものは、6,7または8個のD−グリコピ
ラノース基からなり、それぞれα−5β−5γ−シクロ
デキストリンと呼ばれている。
The main ones are composed of 6, 7 or 8 D-glycopyranose groups and are respectively called α-5β-5γ-cyclodextrins.

本発明におけるシクロテ゛キスI・リンとは、前記α、
β、γ等のシクロデキストリン又はそれらの混合物をい
う。
In the present invention, cyclotex I-phosphorus refers to the above-mentioned α,
Refers to cyclodextrins such as β and γ, or mixtures thereof.

シフロブキス1ヘ9フ分子は多数の1級及び2級水酸基
を有するので、単糖類に広く用いられている反応を適用
して種々の誘導体が得られる。
Since the Sifurobukis 1he9fu molecule has a large number of primary and secondary hydroxyl groups, various derivatives can be obtained by applying reactions widely used for monosaccharides.

本発明におけるシクロデキストリン誘導体とはかかる方
法で得られる誘導体を意味し、例えば、アミノシクロテ
゛キストリンやアミノテ゛オキシシクロデキストリンの
如きアミン化誘導体、アセチルシクロデキストリンやニ
トロシクロデキストリンの如きエステル化誘導体、メチ
ルシクロテ゛キストリン、エチルシクロテ゛キストリン
、プロピルシクロデキストリン、カルボキシメチルシク
ロテ゛キストリンの如きエーテル化誘導体(エーテル化
シクロデキストリン)がある。
Cyclodextrin derivatives in the present invention refer to derivatives obtained by such methods, such as aminated derivatives such as aminocyclodextrin and aminocyclodextrin, esterified derivatives such as acetylcyclodextrin and nitrocyclodextrin, and methylcyclodextrin. There are etherified derivatives (etherified cyclodextrin) such as , ethyl cyclodextrin, propyl cyclodextrin, and carboxymethyl cyclodextrin.

本発明において好ましいのはエーテル化シクロテ゛キス
トリンで゛あり、中で゛も、ヘキサキス(2,6−0−
ジメチル)α−シクロデキストリンやヘプタキス(2,
6−0−ジメチル)β−シクロデキストリン等のメチル
デキストリンが特に好ましい。
Preferred in the present invention are etherified cyclodextrin, among which hexakis(2,6-0-
dimethyl) α-cyclodextrin and heptakis (2,
Methyldextrins such as 6-0-dimethyl)β-cyclodextrin are particularly preferred.

本発明において培地とは、ブイヨンやペプトン水などの
従来公知の液状培地、あるいは液状培地に寒天、ゼラチ
ン、卵白、血清などを加えて固形にした従来公知の固形
培地を意味するが、好ましいのはSS培地、及びこれに
寒天を1〜2%(W/V)程度添加し固化したSS培地
である。
In the present invention, the medium means a conventionally known liquid medium such as bouillon or peptone water, or a conventionally known solid medium made by adding agar, gelatin, egg white, serum, etc. to a liquid medium, but preferred is These are an SS medium and an SS medium obtained by adding about 1 to 2% (w/v) agar to this medium and solidifying it.

SS培地は、11あたり、グルタミン酸ナトリウム、1
−プロリン、塩化ナトリウム、リン酸2水素カリウム、
塩化カリウム、塩化マグネシウム、塩化カルシウム、ト
リスヒドロキシメチルアミノメタンを、それぞれ10,
7.0,24.2,5.0,5゜0.2.0,1.0,
02.1,525gを含む水溶液を濃塩酸で世7.6に
調整した後、121℃で15分間オートクレーブで滅菌
して得られる基礎培地に、■−シスチン、硫酸第1鉄、
アスコルビン酸、ニアシン、還元型グルタチオンを11
あたり、それぞれ4゜1、 2.0,4. Log含む
溶液をミリポアフィルタ−(0,45μ)で除菌して得
られる補液を、基礎培地に対しでて1.0%(V/V)
の割合で加えて得られる。
SS medium contains 11 sodium glutamate, 1
-proline, sodium chloride, potassium dihydrogen phosphate,
10 each of potassium chloride, magnesium chloride, calcium chloride, and trishydroxymethylaminomethane,
7.0, 24.2, 5.0, 5゜0.2.0, 1.0,
After adjusting the aqueous solution containing 1,525 g of 0.02.0.02. to 7.6 g with concentrated hydrochloric acid, sterilize it in an autoclave at 121°C for 15 minutes.
11 ascorbic acid, niacin, and reduced glutathione
4°1, 2.0, 4. A supplementary solution obtained by sterilizing a solution containing Log with a Millipore filter (0.45μ) is 1.0% (V/V) based on the basal medium.
It is obtained by adding in the proportion of .

本発明において、前記培地に添加混合されるシクロデキ
ストリン又はその誘導体の量は、接種される菌の量に依
存するが、例えば、接種される菌が103のコロニーの
場合には200〜5000μg /ml。
In the present invention, the amount of cyclodextrin or its derivative added to the medium depends on the amount of bacteria to be inoculated, but for example, if the bacteria to be inoculated are 103 colonies, it is 200 to 5000 μg/ml. .

106コロロ二−の場合には1〜500μg /mlが
適当である。
In the case of 106 colors, 1 to 500 μg/ml is suitable.

かかる培地を用いたボルテ゛テラ属に属する微生物の培
養方法及び条件は特に限定されるものではなく、従来公
知の方法及び条件を採用できるが、静置培養よりは振と
う培養の方が好ましく、培養温度は35℃前後、培養時
間は10〜100時間が適当である。
The method and conditions for culturing microorganisms belonging to the genus Volteterra using such a medium are not particularly limited, and conventionally known methods and conditions can be employed, but shaking culture is preferable to static culture, and culture temperature The appropriate temperature is around 35°C and the culture time is 10 to 100 hours.

以下、実施例により本発明を詳述する。Hereinafter, the present invention will be explained in detail with reference to Examples.

実施例 1 ボルデテラパタシス(Bordetellapertu
ssis )(百日咳菌)東浜株I相菌の凍結乾燥菌体
を1%カザミノ酸溶液に懸濁させ、脱繊維馬血液を20
%含むボルナ・シャングー(Bnrdet −Geng
ou)培地(以下BG培地という)で35℃、3日間培
養した。
Example 1 Bordetella pertu
ssis ) (Bacillus pertussis) Higashihama strain I freeze-dried cells were suspended in a 1% casamino acid solution, and defibrinated horse blood was added to
Borna Shangu (Bnrdet-Geng) containing %
ou) medium (hereinafter referred to as BG medium) at 35°C for 3 days.

この菌を1白金耳かき取り、更にBG培地で24時間リ
フレッシュした菌をSS培地に懸濁し、5×103コロ
ニー/mlの接種菌懸濁液を得た。
One platinum loopful of the bacteria was scraped off, and the bacteria was refreshed with BG medium for 24 hours and suspended in SS medium to obtain an inoculated bacterial suspension of 5 x 103 colonies/ml.

予め所定の終濃度(μg /ml)となるように、シク
ロデキストリン又はその誘導体を含む1.2%寒天濃度
の固型SS培地を調製しておき、1プレート当りの菌数
が103コロニーとなるようにスプレッドした。
Prepare in advance a solid SS medium containing cyclodextrin or its derivatives at a concentration of 1.2% agar so that it has a predetermined final concentration (μg/ml), and the number of bacteria per plate is 103 colonies. It was spread like this.

35℃で4日間培養後の菌生育状態(コロニー数)を第
1表に示した。
Table 1 shows the bacterial growth status (number of colonies) after culturing at 35°C for 4 days.

なお、用いたエーテル化シクロテ゛キストリンは 、
H,5chlenk ら の 方 法(Ab
str、Pap、Amer、Chem、5oc0、14
9、 lIC11965参照)に準拠して合成された。
The etherified cyclodextrin used was
H, 5chlenk et al.'s method (Ab
str, Pap, Amer, Chem, 5oc0, 14
9, IC11965).

以下、α−シクロデキストリンをα−CD、そのメチル
化物(ヘキサキス(2,6−0−ジメチル)α−シクロ
テ゛キストリン)をMeα−CD、エチル化物をEtα
−CD、β−シクロテ゛キストリンをβ−CD、そのメ
チル化物をMeβ−CD (ヘプタキス(2,6−0−
ジメチル)β−シクロデキストリン)、エチル化物をE
tβ−CDと略記する。
Hereinafter, α-cyclodextrin is α-CD, its methylated product (hexakis(2,6-0-dimethyl)α-cyclodextrin) is Meα-CD, and its ethylated product is Etα.
-CD, β-cyclotexttrin as β-CD, its methylated product as Meβ-CD (heptakis(2,6-0-
dimethyl)β-cyclodextrin), ethylated product as E
It is abbreviated as tβ-CD.

第1表から明らかな如く、シクロデキストリン又はその
誘導体を培地に添加することにより、百日咳菌の生育が
促進されている。
As is clear from Table 1, the growth of Bordetella pertussis is promoted by adding cyclodextrin or its derivative to the medium.

また、その効果はα−CD又はβ−CDよりもそれらの
メチル化物又はエチル化物の方が優れており、α体より
もβ体の方がより優れていることがわかる。
Furthermore, it can be seen that the methylated or ethylated products thereof are better than α-CD or β-CD, and the β-form is better than the α-form.

実施例 2 実施例1と同様の方法で得られた接種菌懸濁液を、所定
濃度のMeβ−CDを含むSS液体培地10m1に接種
サイズが106コロニーとなるように接種し、L字型試
験管で往復振とうしながら35℃で培養した。
Example 2 The inoculum suspension obtained in the same manner as in Example 1 was inoculated into 10 ml of SS liquid medium containing a predetermined concentration of Meβ-CD so that the inoculation size was 106 colonies, and an L-shaped test was conducted. The cells were cultured at 35°C with reciprocal shaking in tubes.

得られた培地の濁度(OD650mμ)の経時変化は第
2表の通であった。
The changes over time in the turbidity (OD650 mμ) of the obtained medium were as shown in Table 2.

第2表より、Meβ−CDを培地に1〜500μg/m
lの範囲で添加すると、添加量の増大と共に培地の濁度
が増大、即ち菌の生育が促進されていることがわかる。
From Table 2, Meβ-CD was added to the medium at 1 to 500 μg/m.
It can be seen that when added within the range of 1, the turbidity of the medium increases as the amount added increases, that is, the growth of bacteria is promoted.

Claims (1)

【特許請求の範囲】 1 ボルデテラ(Bordetella)属に属する微
生物を培養するに際し、培地中にシクロデキストリン又
はその誘導体を加えることを特徴とする、ボルデテラ属
に属する微生物の培養方法。 2 シクロデキストリンの誘導体がエーテル化シクロデ
キストリンである、特許請求の範囲第1項記載の培養方
法。 3 エーテル化シクロデキストリンがメチルシクロデキ
ストリンである、特許請求の範囲第2項記載の培養方法
。 4 ボルデテラ属に属する微生物を培養するための、シ
クロデキストリン又はその誘導体を含有する培地。 5 シクロデキストリン又はその誘導体を1〜5000
μg /mlの割合で含有する、特許請求の範囲第4項
記載の培地。
[Scope of Claims] 1. A method for culturing a microorganism belonging to the genus Bordetella, which comprises adding cyclodextrin or a derivative thereof to a medium when culturing the microorganism belonging to the genus Bordetella. 2. The culture method according to claim 1, wherein the cyclodextrin derivative is an etherified cyclodextrin. 3. The culture method according to claim 2, wherein the etherified cyclodextrin is methylcyclodextrin. 4. A medium containing cyclodextrin or a derivative thereof for culturing microorganisms belonging to the genus Bordetella. 5 Cyclodextrin or its derivatives from 1 to 5000
The culture medium according to claim 4, which contains the medium in a proportion of μg/ml.
JP16347781A 1981-10-15 1981-10-15 Culture method and medium Expired JPS5953833B2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP16347781A JPS5953833B2 (en) 1981-10-15 1981-10-15 Culture method and medium
US06/427,039 US4500639A (en) 1981-10-15 1982-09-29 Culturing Bordetella in media containing etherified cyclodextrin
AU89192/82A AU554066B2 (en) 1981-10-15 1982-10-07 Cyclodextrin additive to bordetella culture medium
CA000413002A CA1198702A (en) 1981-10-15 1982-10-07 Method of culturing microbes belonging to the genus bordetella and culture medium
ES516507A ES8404407A1 (en) 1981-10-15 1982-10-14 Method of culturing microbes belonging to the genus Bordetella and culture medium.
DE8282305465T DE3279841D1 (en) 1981-10-15 1982-10-14 Method of culturing microbes belonging to the genus bordetella and culture medium
AT82305465T ATE44979T1 (en) 1981-10-15 1982-10-14 PROCEDURE FOR CULTIVATION OF BORDETELLA GENUS MICROBES AND AGAR.
EP82305465A EP0077646B1 (en) 1981-10-15 1982-10-14 Method of culturing microbes belonging to the genus bordetella and culture medium
SU823505901A SU1384206A3 (en) 1981-10-15 1982-10-15 Method of cultivating bacteria bordetella pertussis
KR8204639A KR870001650B1 (en) 1981-10-15 1982-10-15 Culturing method and medium of bordetella micro-organism
MYPI87000101A MY100052A (en) 1981-10-15 1987-02-05 Method of culturing microbes belonging to the genus bordetella and culture medium.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16347781A JPS5953833B2 (en) 1981-10-15 1981-10-15 Culture method and medium

Publications (2)

Publication Number Publication Date
JPS5867182A JPS5867182A (en) 1983-04-21
JPS5953833B2 true JPS5953833B2 (en) 1984-12-27

Family

ID=15774613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16347781A Expired JPS5953833B2 (en) 1981-10-15 1981-10-15 Culture method and medium

Country Status (1)

Country Link
JP (1) JPS5953833B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0147685B1 (en) * 1983-12-17 1989-04-26 Hoechst Aktiengesellschaft Beta-cyclodextrin and process for its preparation
JPS61271986A (en) * 1985-05-27 1986-12-02 Agency Of Ind Science & Technol Culture medium for lymphatic cell
GB201316351D0 (en) * 2013-09-13 2013-10-30 Glaxosmithkline Biolog Sa

Also Published As

Publication number Publication date
JPS5867182A (en) 1983-04-21

Similar Documents

Publication Publication Date Title
EP0017242B1 (en) A process for producing cyclodextrins
Robyt et al. Isolation, purification, and characterization of a maltotetraose-producing amylase from Pseudomonas stutzeri
US4965205A (en) Culture medium for bacteria of the bordetella genus containing etherified derivative of D-glucose and a cyclodextrin
Melvaer et al. A charged component in purified polysaccharide preparations from Streptococcus mutans and Streptococcus sanguis
US4642288A (en) Process for producing thermostable alpha-amylases by culturing micro-organisms at elevated temperatures
Dlamini et al. Production of exopolysaccharide by Pseudomonas sp. ATCC 31461 (Pseudomonas elodea) using whey as fermentation substrate
JPH0138476B2 (en)
TW434313B (en) Process for producing hyaluronic acid using a mutant strain of streptococcus zooepidemicus capable of producing hyaluronic acid at high yield
JP3555957B2 (en) Klebsiella pneumoniae, subsp. Novel strain of Pneumoniae and method for producing L-fucose-containing polysaccharide
US4500639A (en) Culturing Bordetella in media containing etherified cyclodextrin
JPS5953833B2 (en) Culture method and medium
DE69003252T2 (en) METHOD FOR THE ENZYMATIC CONVERSION OF STARCH IN CYCLODEXTRINE.
US5342773A (en) Endoglycanase isolated from bacillus ATCC 55294
JPS59187778A (en) Culture medium for cultivating microorganism
JP3250852B2 (en) Novel cyclodextrin-glucanotransferase produced by Bacillus megaterium, method for producing the same, and method for producing cyclodextrin using the enzyme
KR830002250B1 (en) Preparation of Cyclodextrine
JPS62232380A (en) Bacillus sp.kk-4645
JPH04237496A (en) Production of cyclic inulo oligosaccharide
JPH0761264B2 (en) Novel cyclomaltodextrinase and method for producing the same
JP3025974B2 (en) Novel enzyme, method for producing the same, and method for producing maltooligosaccharide using the same
JP3183970B2 (en) Method for producing cyclomaltodextrin glucanotransferase
JPH08256766A (en) Cyclodextrin glucanotransferase and its production
JPH022881B2 (en)
HUT53933A (en) Process for producing new cyclodextrine glycosyl transferases
JPH0632611B2 (en) γ-Cyclodextrin synthase and method for producing the same